← Back to headlines
Syndax Pharmaceuticals Highlights Sales Surge and 2026 Milestones
Syndax Pharmaceuticals has reported a significant increase in sales for Revuforj and Niktimvo, while also outlining key milestones anticipated for 2026 at a Guggenheim conference.
15 Feb, 13:05 — 15 Feb, 13:05
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Americans Reduce Retirement Savings Amid Rising Recession Fears
just now
KuCoin Invests $2 Billion to Enhance Exchange Trustworthiness
just now
Retirement Savings Trends for Americans Aged 65-74 Revealed
just now
Paloma Partners Reduces Core Scientific Position as Mining Efficiency and Costs Shape the Bitcoin Cycle
7m ago